一種非創(chuàng)傷性血液檢測(cè)方法被研制開發(fā)用于確定胎兒是否面臨出現(xiàn)遺傳疾病的危險(xiǎn)。

對(duì)出生前遺傳疾病的診斷，目前依靠在妊娠10-20周的時(shí)候通過創(chuàng)傷性操作獲得的胎兒組織進(jìn)行檢查，而這往往會(huì)導(dǎo)致自發(fā)性流產(chǎn)。游離胎兒DNA(ffDNA)早在妊娠早期（6周）的時(shí)候就會(huì)出現(xiàn)在母體血液之中，能夠用于出生前診斷，從而避免侵入性檢查，極大地造福了父母，他們其中許多在孕期已經(jīng)受到了影響。
 
Blood Test Determines Genetic Risks in Fetus
 
A non-invasive blood test has been developed that determines whether a fetus is at risk of developing genetic diseases.

Prenatal diagnosis of genetic diseases currently depends on the investigation of fetal tissue obtained between 10 and 20 weeks gestation by invasive procedures that can cause spontaneous abortion. Free fetal DNA (ffDNA) is present in maternal blood from early in gestation (six weeks) and its use for prenatal diagnosis could avoid invasive testing, with considerable benefit to parents, many of whom will already have had an affected pregnancy.